• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD NEXIVA DIFFUSICS 24G X 0.75 IN; INTRAVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD NEXIVA DIFFUSICS 24G X 0.75 IN; INTRAVASCULAR CATHETER Back to Search Results
Model Number 383590
Device Problem Fail-Safe Problem (2936)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 06/08/2023
Event Type  malfunction  
Event Description
It was reported while using bd nexiva diffusics 24g x 0.75 in the safety mechanism broke.There was no report of patient impact.The following information was provided by the initial reporter: it was reported, rn was placing a diffusics 24g on a patient when she threaded the catheter and pulled the needle back, the safety feature did not engage and popped right off the top with the whole needle exposed.No employee stick, no harm to patient.
 
Manufacturer Narrative
E.4.: the initial reporter also notified the fda on 08jun2023.Medwatch report #mw5118345 h.3.A device evaluation and/or device history review is anticipated but is not complete.Upon completion, a supplemental report will be filed.
 
Manufacturer Narrative
H6: investigation summary: no photos or samples were received by our quality team for evaluation therefore the failure mode could not be verified.A review of the internal manufacturing device records and raw material history files for the reported lot numbers was performed and no recorded quality problems or rejections to this incident were found.Based on the quality team's investigation, the root cause of this incident cannot be determined.
 
Event Description
It was reported while using bd nexiva diffusics 24g x 0.75 in the safety mechanism broke.There was no report of patient impact.The following information was provided by the initial reporter: it was reported, rn was placing a diffusics 24g on a patient when she threaded the catheter and pulled the needle back, the safety feature did not engage and popped right off the top with the whole needle exposed.No employee stick, no harm to patient.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD NEXIVA DIFFUSICS 24G X 0.75 IN
Type of Device
INTRAVASCULAR CATHETER
Manufacturer (Section D)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer (Section G)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8448235433
MDR Report Key17313541
MDR Text Key319497537
Report Number1710034-2023-00791
Device Sequence Number1
Product Code FOZ
UDI-Device Identifier30382903835905
UDI-Public(01)30382903835905
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K123734
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other
Reporter Occupation Risk Manager
Type of Report Initial,Followup
Report Date 07/18/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Model Number383590
Device Catalogue Number383590
Device Lot Number3010847
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 06/20/2023
Initial Date FDA Received07/12/2023
Supplement Dates Manufacturer Received07/18/2023
Supplement Dates FDA Received08/04/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/01/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-